2cureX oversubscribed share issue to fund IndiTreat rollout
2cureX says an oversubscribed share issue and IndiTreatⓇ hospital rollout support a strategic transition amid Nasdaq delisting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.